Comparative study of an angiotensin-II analog and a converting enzyme inhibitor

This publication has 23 references indexed in Scilit:

• Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients
  Annals of Internal Medicine, 1979
• Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients
  Progress in Cardiovascular Diseases, 1978
• Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man
  New England Journal of Medicine, 1978
• Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man
  European Journal of Clinical Investigation, 1977
• Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents
  Science, 1977
• Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin
  The American Journal of Medicine, 1976
• The Effects of Saralasin, an Angiotensin II Antagonist on Blood Pressure and the Renin‐Angiotensin‐Aldosterone System in Normal and Hypertensive Subjects
  Australian and New Zealand Journal of Medicine, 1976
• Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patients
  The American Journal of Medicine, 1976
• Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” Hypertension
  New England Journal of Medicine, 1975
• A Specific Competitive Antagonist of the Vascular Action of Angiotensin II
  Circulation Research, 1971